GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (LSE:DDDD) » Definitions » Total Assets

4d pharma (LSE:DDDD) Total Assets : £42.94 Mil (As of Dec. 2021)


View and export this data going back to 2014. Start your Free Trial

What is 4d pharma Total Assets?

4d pharma's Total Assets for the quarter that ended in Dec. 2021 was £42.94 Mil.

Total Assets is connected with ROA %. 4d pharma's annualized ROA % for the quarter that ended in Dec. 2021 was -158.73%. Total Assets is also linked to Revenue through Asset Turnover. 4d pharma's Asset Turnover for the quarter that ended in Dec. 2021 was 0.01.


4d pharma Total Assets Historical Data

The historical data trend for 4d pharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma Total Assets Chart

4d pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Assets
Get a 7-Day Free Trial 77.74 52.61 31.14 35.42 42.94

4d pharma Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.14 39.95 35.42 47.65 42.94

4d pharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

4d pharma's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Assets=Total Equity (A: Dec. 2021 )+Total Liabilities (A: Dec. 2021 )
=23.198+19.742
=42.94

4d pharma's Total Assets for the quarter that ended in Dec. 2021 is calculated as

Total Assets=Total Equity (Q: Dec. 2021 )+Total Liabilities (Q: Dec. 2021 )
=23.198+19.742
=42.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4d pharma  (LSE:DDDD) Total Assets Explanation

Total Assets is connected with ROA %.

4d pharma's annualized ROA % for the quarter that ended in Dec. 2021 is

ROA %=Net Income (Q: Dec. 2021 )/( (Total Assets (Q: Jun. 2021 )+Total Assets (Q: Dec. 2021 ))/ count )
=-71.896/( (47.647+42.94)/ 2 )
=-71.896/45.2935
=-158.73 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2021) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

4d pharma's Asset Turnover for the quarter that ended in Dec. 2021 is

Asset Turnover
=Revenue (Q: Dec. 2021 )/( (Total Assets (Q: Jun. 2021 )+Total Assets (Q: Dec. 2021 ))/ count )
=0.29/( (47.647+42.94)/ 2 )
=0.29/45.2935
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

4d pharma Total Assets Related Terms

Thank you for viewing the detailed overview of 4d pharma's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


4d pharma (LSE:DDDD) Business Description

Traded in Other Exchanges
N/A
Address
9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.

4d pharma (LSE:DDDD) Headlines

No Headlines